Glioblastome (IDH-Wildtyp, MGMT-Promoter-Methylierung). Astrozytome (IDH-mutiert, ATRX-Verlust). Oligodendrogliome (1p/19q-Kodeletion). Ependymome (ZFTA-Fusion). Meningeome (WHO-Grad 1-3, PR-Status).